Get the Stockscreener App
3.9317
6.05%
-0.2533
After Hours:
4.12
0.1883
+4.79%
Apollomics Inc stock is traded at $3.9317, with a volume of 81,747.
It is down -6.05% in the last 24 hours and down -35.97% over the past month.
Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.
See More
Previous Close:
$4.185
Open:
$4.19
24h Volume:
81,747
Relative Volume:
2.86
Market Cap:
$4.34M
Revenue:
-
Net Income/Loss:
$-57.11M
P/E Ratio:
-0.2621
EPS:
-15
Net Cash Flow:
$-34.82M
1W Performance:
-34.96%
1M Performance:
-35.97%
6M Performance:
-39.51%
1Y Performance:
-69.21%
1-Day Range:
$3.659
$4.2087
1-Week Range:
$3.659
$6.37
52-Week Range:
$3.659
$35.98
Apollomics Inc Stock (APLM) Company Profile
Compare APLM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
APLM
Apollomics Inc
|
3.9317 | 4.62M | 0 | -57.11M | -34.82M | -15.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Apollomics Inc Stock (APLM) Latest News
Published on: 2025-09-01 20:18:17 - Newser
How cyclical is Apollomics Inc. Equity Warrant’s revenue streamJuly 2025 Sector Moves & Smart Money Movement Tracker - خودرو بانک
Relative strength of Apollomics Inc. Equity Warrant in sector analysisSell Signal & Free Safe Capital Growth Stock Tips - Newser
Backtesting results for Apollomics Inc. trading strategies2025 Price Targets & Entry Point Confirmation Alerts - Newser
Is it time to cut losses on Apollomics Inc.2025 Macro Impact & Free Safe Capital Growth Stock Tips - Newser
Apollomics Inc. Equity Warrant stock daily chart insightsWeekly Trade Review & Capital Efficient Trading Techniques - Newser
Apollomics Inc. Stocks Attracting Dip BuyersPortfolio Value Summary & Community Driven Trade Alerts - beatles.ru
Leading vs lagging indicators on Apollomics Inc. performanceStock Surge & Low Drawdown Momentum Ideas - Newser
Is it time to cut losses on Apollomics Inc. Equity WarrantJuly 2025 Earnings & Reliable Momentum Entry Alerts - Newser
Visualizing Apollomics Inc. stock with heatmapsJuly 2025 Big Picture & Risk Controlled Daily Plans - Newser
Order flow analysis tools used on Apollomics Inc.2025 Year in Review & Free Community Consensus Stock Picks - Newser
Analyzing Apollomics Inc. Equity Warrant with multi timeframe chartsMarket Volume Report & Technical Analysis for Trade Confirmation - Newser
Regression analysis insights on Apollomics Inc. performanceTrade Risk Assessment & Reliable Price Action Trade Plans - Newser
What recovery options are there for Apollomics Inc. Equity WarrantWeekly Risk Report & Community Consensus Picks - Newser
Published on: 2025-08-31 12:41:40 - Newser
Real time social sentiment graph for Apollomics Inc.July 2025 Setups & Safe Capital Allocation Plans - Newser
Top chart patterns to watch in Apollomics Inc. Equity Warrant2025 AllTime Highs & Technical Analysis for Trade Confirmation - Newser
Will Apollomics Inc. Recover After Recent Decline getLinesFromResByArray error: size == 0 - thegnnews.com
News impact scoring models applied to Apollomics Inc.Bear Alert & AI Powered Buy/Sell Recommendations - Newser
Can Apollomics Inc. Equity Warrant rally from current levelsJuly 2025 Highlights & Safe Swing Trade Setup Alerts - Newser
Chart overlay techniques for tracking Apollomics Inc.Weekly Market Report & Reliable Price Breakout Signals - Newser
What to do if you’re stuck in Apollomics Inc. Equity Warrant2025 Stock Rankings & Long-Term Safe Investment Plans - Newser
Analyzing net buyer seller activity in Apollomics Inc.July 2025 PostEarnings & AI Based Buy/Sell Signal Reports - Newser
Is now a turning point for Apollomics Inc. Equity Warrant2025 Trade Ideas & Scalable Portfolio Growth Ideas - Newser
Earnings Chart Overlay Points to Apollomics Inc. Equity Warrant Upside2025 Market Trends & AI Driven Stock Price Forecasts - beatles.ru
Detecting support and resistance levels for Apollomics Inc.Earnings Recap Summary & Proven Capital Preservation Methods - Newser
Published on: 2025-08-30 23:31:06 - Newser
Published on: 2025-08-30 22:30:16 - Newser
Is Apollomics Inc. a candidate for recovery play2025 Support & Resistance & Safe Swing Trade Setups - Newser
Is Apollomics Inc. Equity Warrant stock bottoming outWeekly Market Report & Technical Pattern Based Signals - Newser
Is It Too Late to Sell Apollomics Inc. getLinesFromResByArray error: size == 0 - thegnnews.com
Trading Bots Trigger Alerts on Apollomics Inc. Equity Warrant Activity getLinesFromResByArray error: size == 0 - kangso.co.kr
Machine Learning Models Forecast Apollomics Inc. Equity Warrant UptickLayoff News & Verified Momentum Watchlists - beatles.ru
Published on: 2025-08-30 11:41:30 - Newser
Apollomics Inc Stock (APLM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.96%
1.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):